Abstract |
A 40-year-old female with a recurrent mixed astrocytoma/ oligodendroglioma was treated with intra-arterial BCNU at six week intervals. Phosphorus magnetic resonance spectroscopy was performed before, and on two occasions after her third treatment. Before treatment, phosphodiesters were 25% less than normal and intracellular pH was 7.14 (normal 6.97 +/- 0.02). Eight hours following treatment phosphocreatine and phosphodiesters were reduced by approximately 40% and pHi increased to 7.24. Thirty-two hours after treatment, phosphocreatine and phosphodiesters had reversed their decline, but pHi had increased further to 7.35. MRI and x-ray CT scans did not show any change during this period. This study demonstrates that chemical changes can be observed in a glioma by magnetic resonance spectroscopy shortly after chemotherapy in a clinical setting and before changes are observable by imaging modalities. This approach evidently offers a possible means of monitoring the acute metabolic response of tumours to chemotherapy or other forms of treatment by a non-invasive repeatable quantitative method.
|
Authors | D L Arnold, E A Shoubridge, W Feindel, J G Villemure |
Journal | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
(Can J Neurol Sci)
Vol. 14
Issue 4
Pg. 570-5
(Nov 1987)
ISSN: 0317-1671 [Print] England |
PMID | 3690427
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Astrocytoma
(drug therapy, metabolism)
- Brain Neoplasms
(drug therapy, metabolism)
- Carmustine
(administration & dosage)
- Combined Modality Therapy
- Energy Metabolism
(drug effects)
- Female
- Humans
- Infusions, Intra-Arterial
- Magnetic Resonance Spectroscopy
- Neoplasms, Multiple Primary
(drug therapy, metabolism)
- Oligodendroglioma
(drug therapy, metabolism)
- Phosphates
(metabolism)
|